Carl Zeiss Meditec AG (XSWX:AFX) Interest Paid

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:AFX Carl Zeiss Meditec AG XSWX:AFX
78 GF Score
Price CHF28.46
GF Value CHF71.65
! 4 Warning Signs
View Full Analysis

What is Carl Zeiss Meditec AG Interest Paid?

Interest Paid only applicable to companies reporting Cash Flow from Operations in direct method.

XSWX:AFX
78GF Score
Carl Zeiss Meditec AG XSWX:AFX
Interest Paid is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Carl Zeiss Meditec AG (XSWX:AFX) Overvalued in 2026?

Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued. The current stock price of CHF28.46 is trading 60.3% below its estimated GF Value™ of CHF71.65.

Key valuation signals for XSWX:AFX:

  • Interest Paid:
  • GF Value™: CHF71.65 vs. price of CHF28.46 (60.3% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the XSWX:AFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carl Zeiss Meditec AG Business Description

Address Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec AG is a German medical technology company specializing in ophthalmic devices and microsurgery equipment. It operates through two segments: Ophthalmology, which supplies diagnostic and surgical systems, refractive lasers, intraocular lenses, and disposable instruments used in cataract and vision-correction procedures, and Microsurgery, which provides visualization systems, surgical instruments, and implants for neurosurgery, spine surgery, and otolaryngology. The company serves hospitals, clinics, surgical centers, and eye-care practices worldwide, selling directly and through distributors. Revenue comes mainly from equipment sales, recurring consumables and implants, and service contracts. Europe, the Americas, and Asia-Pacific, particularly China and Japan, are key markets. Carl Zeiss Meditec is majority-owned by Carl Zeiss AG and is listed on the Frankfurt Stock Exchange.
78GF Score

Get the complete analysis for XSWX:AFX

Interest Paid is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF28.46
Price
CHF71.65
GF Value